From: Could admission level of uric acid predict total diuretic dose in acute heart failure?
Time | Medications | Group A (Frequency/Percentage) | Group B (Frequency/Percentage) | Total (Frequency/Percentage) | P-value |
---|---|---|---|---|---|
Medications used before hospitalization | Calcium channel blockers | 3/4.4 | 2/11.1 | 5/5.8 | 0.280 |
Furosemide | 42/61.8 | 7/38.9 | 49/57 | 0.081 | |
ACE inhibitors | 18/26.5 | 3/16.7 | 21/24.4 | 0.389 | |
Angiotensin receptor blockers | 23/33.3 | 4/22.2 | 27/31 | 0.364 | |
Beta-blockers | 40/58.8 | 4/22.2 | 44/51.2 | 0.006 | |
Spironolactone | 24/35.3 | 3/16.7 | 27/31.4 | 0.130 | |
Digoxin | 24/35.3 | 4/22.2 | 28/32.6 | 0.293 | |
Nitrate-based vasodilators | 7/10.3 | 1/5.6 | 8/9.3 | 0.538 | |
Medications used during hospitalization | ACE inhibitor | 58/73.4 | 11/52.4 | 69/69 | 0.064 |
Angiotensin receptor blockers | 2/2.5 | 0/0 | 2/2 | 0.461 | |
Inotrope | 24/30.8 | 3/14.3 | 27/27 | 0.132 | |
Nitrate-based vasodilators | 9/11.4 | 0/0 | 9/9 | 0.105 | |
Spironolactone | 58/73.4 | 17/22.7 | 75/75 | 0.478 | |
Beta-blockers | 69/87.3 | 16/76.2 | 85/85 | 0.203 | |
Allopurinol | 2/2.5 | 0/0 | 2/2 | 0.461 | |
Digoxin | 30/38.5 | 2/6.3 | 32/32 | 0.012 |